Literature DB >> 15831952

Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities.

Thomas J Chambers1, Deborah A Droll1, Yujia Tang1, Yan Liang1, Vannakambadi K Ganesh2, Krishna H M Murthy2, Michael Nickells1.   

Abstract

A series of 46 charged-to-alanine mutations in the yellow fever virus NS2B-NS3 protease, previously characterized in cell-free and transient cellular expression systems, was tested for their effects on virus recovery. Four distinct plaque phenotypes were observed in cell culture: parental plaque-size (13 mutants), reduced plaque-size (17 mutants), small plaque-size (8 mutants) and no plaque-formation (8 mutants). No mutants displayed any temperature sensitivity based on recovery of virus after RNA transfection at 32 versus 37 degrees C. Most small plaque-mutants were defective in growth efficiency compared with parental virus. However not all small plaque-mutants had defective 2B/3 cleavage, with some showing selective defects at other non-structural protein cleavage sites. Revertant viruses were recovered for six mutations that caused reduced plaque sizes. Same-site and second-site mutations occurred in NS2B, and one second-site mutation occurred in the NS3 protease domain. Some reversion mutations ameliorated defects in cleavage activity and plaque size caused by the original mutation. These data indicate that certain mutations that reduce NS2B-NS3 protease cleavage activity cause growth restriction of yellow fever virus in cell culture. However, for at least two mutations, processing defects other than impaired cleavage activity at the 2B/3 site may account for the mutant phenotype. The existence of reversion mutations primarily in NS2B rather than NS3, suggests that the protease domain is less tolerant of structural perturbation compared with the NS2B protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831952     DOI: 10.1099/vir.0.80427-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis.

Authors:  Sergey A Shiryaev; Boris I Ratnikov; Alexander E Aleshin; Igor A Kozlov; Nicholas A Nelson; Michal Lebl; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

2.  A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.

Authors:  Alexander A Rumyantsev; Brian R Murphy; Alexander G Pletnev
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Transmembrane Domains of NS2B Contribute to both Viral RNA Replication and Particle Formation in Japanese Encephalitis Virus.

Authors:  Xiao-Dan Li; Cheng-Lin Deng; Han-Qing Ye; Hong-Lei Zhang; Qiu-Yan Zhang; Dong-Dong Chen; Pan-Tao Zhang; Pei-Yong Shi; Zhi-Ming Yuan; Bo Zhang
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

4.  Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.

Authors:  Sergey A Shiryaev; Anton V Cheltsov; Katarzyna Gawlik; Boris I Ratnikov; Alex Y Strongin
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

5.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

6.  Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.

Authors:  Sergey A Shiryaev; Chen Farhy; Antonella Pinto; Chun-Teng Huang; Nicole Simonetti; Annie Elong Ngono; Antimone Dewing; Sujan Shresta; Anthony B Pinkerton; Piotr Cieplak; Alex Y Strongin; Alexey V Terskikh
Journal:  Antiviral Res       Date:  2017-04-29       Impact factor: 5.970

7.  Isolation and characterization of selective and potent human Fab inhibitors directed to the active-site region of the two-component NS2B-NS3 proteinase of West Nile virus.

Authors:  Sergey A Shiryaev; Ilian A Radichev; Boris I Ratnikov; Alexander E Aleshin; Katarzyna Gawlik; Boguslaw Stec; Christian Frisch; Achim Knappik; Alex Y Strongin
Journal:  Biochem J       Date:  2010-04-14       Impact factor: 3.857

8.  Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis.

Authors:  Eric F Donaldson; Amy C Sims; Rachel L Graham; Mark R Denison; Ralph S Baric
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

9.  Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.

Authors:  Zhili Zuo; Oi Wah Liew; Gang Chen; Pek Ching Jenny Chong; Siew Hui Lee; Kaixian Chen; Hualiang Jiang; Chum Mok Puah; Weiliang Zhu
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

10.  Analysis of murine hepatitis virus strain A59 temperature-sensitive mutant TS-LA6 suggests that nsp10 plays a critical role in polyprotein processing.

Authors:  Eric F Donaldson; Rachel L Graham; Amy C Sims; Mark R Denison; Ralph S Baric
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.